Somerset Indus Capital Partners has closed its third fund at $288 million, exceeding its initial target, and plans to make around 10 investments across healthcare, as it doubles down on India’s growing opportunity in the sector.
Partner Mayur Sirdesai said strong institutional interest was driven by the firm’s track record and shifting investor focus. “We have been able to, over the last 15 years, demonstrate that we can create good returns along with impact,” he said, adding that India is now seen as a standalone investment destination rather than part of broader emerging markets.
He noted that healthcare is no longer just a defensive play. “Healthcare was always looked at as a recession-resistant area. What has changed today is that healthcare is a strong growth story,” he said.
The fund will target the “missing middle” — a 400–500 million population segment — where access to affordable, quality care remains limited. Sirdesai said the firm sees opportunities across hospitals, pharma, medtech and diagnostics, with rising traction in digital health, insurance and healthcare financing.
“We will look at somewhere in the range of about 10 investments,” he said, highlighting broad-based growth across segments.
First Published: Apr 7, 2026 10:22 PM IST
